| 1 |
28391873 | IL-10 and IL-28B gene variants as predictors of sustained response to peginterferon and ribavirin therapy in chronic HCV infection. | 2022 Mar |
1 |
| 2 |
34216268 | Correlation between IL-28 polymorphism and spontaneous clearance in HCV patients: systematic review and meta-analysis. | 2021 Sep |
1 |
| 3 |
34307188 | Interferon-lambda 3 and 4 Polymorphisms Increase Sustained Virological Responses and Regulate Innate Immunity in Antiviral Therapy With Pegylated Interferon-Alpha. | 2021 |
1 |
| 4 |
32749108 | Association of Interleukin 28B Polymorphism with Clearance of Hepatitis C Virus: A Mini Review. | 2020 |
1 |
| 5 |
33612760 | Interferon-γ inducible protein-10 and interleukin 28B gene polymorphism as predictive markers for genotype 4 hepatitis C virus treatment response. | 2020 Dec 1 |
1 |
| 6 |
30027841 | Genetic Polymorphisms within Interferon-λ Region and Interferon-λ3 in the Human Pathophysiology: Their Contribution to Outcome, Treatment, and Prevention of Infections with Hepatotropic Viruses. | 2019 |
1 |
| 7 |
30988680 | The interleukin 28B gene polymorphism, rs8099917, in patients with chronic hepatitis C and response to the treatment with pegylated interferon and ribavirin. | 2019 |
3 |
| 8 |
31383827 | The Role of Hepatitis C Virus NS5A Region Mutation and SNP IL-28B of Host to Support Successful Pegylated Interferon and Ribavirin Treatment in Patients with HCV-HIV Coinfection: A Prospective Cohort Study. | 2019 Apr |
1 |
| 9 |
29271328 | Influence of IL28B and MxA gene polymorphisms on HCV clearance in Han Chinese population. | 2018 Feb |
1 |
| 10 |
29509884 | Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study. | 2018 Jun 1 |
1 |
| 11 |
29705128 | Identifying causal variants at the interferon lambda locus in case-control studies: Utilizing non-synonymous variant rs117648444 to probe the role of IFN-λ4. | 2018 Jul 20 |
1 |
| 12 |
29851985 | Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens. | 2018 |
3 |
| 13 |
29910570 | The Role of Biochemical Variations and Genotype Testing in Determining the Virological Response of Patients Infected with Hepatitis C Virus. | 2018 Apr-Jun |
1 |
| 14 |
30383478 | Predictive value of IL-28B rs12979860 variants for peg-IFN, sofosbuvir plus ribavirin treatment of HCV infection in Pakistani population. | 2018 Nov |
1 |
| 15 |
26521772 | Editorial: New Therapies, Markers and Therapeutic Targets in HCV Chronic Infection and HCV Extrahepatic Manifestations. | 2017 |
1 |
| 16 |
28036111 | Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients. | 2017 Jul |
1 |
| 17 |
28315743 | Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective study. | 2017 Jul |
3 |
| 18 |
28739427 | The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection. | 2017 Oct |
4 |
| 19 |
28852525 | Real world experience with pegylated interferon and ribavirin in hepatitis C genotype 1 population with favourable IL28B polymorphism. | 2017 Aug |
3 |
| 20 |
28992878 | Peginterferon alfa-2a for the treatment of chronic hepatitis C in the era of direct-acting antivirals. | 2017 Oct 15 |
1 |
| 21 |
29062905 | The impact of the recipient and donor interferon lambda-3 polymorphism on the course of HCV infection following liver transplantation. | 2017 Sep |
1 |
| 22 |
29104462 | Association of IFNL3 Genotype with Hepatic Steatosis in Chronic Hepatitis C Patients Treated with Peginterferon and Ribavirin Combination Therapy. | 2017 |
3 |
| 23 |
29284412 | CCL4 is the only predictor for non-responder in GT-1 CHC patients with favorable IL28B genotype when treated with PegIFN/RBV. | 2017 Dec 29 |
1 |
| 24 |
26280154 | Polymorphisms at IL28B gene as predictors of viral relapse in genotype 4 Egyptian hepatitis C patients. | 2016 Mar |
1 |
| 25 |
26289410 | Effect of native vitamin D3 supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin. | 2016 Mar |
1 |
| 26 |
26344576 | High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV-infected patients regardless of DPP4 activity. | 2016 Mar |
1 |
| 27 |
26825765 | Peginterferon Therapy in Children With Chronic Hepatitis C: A Nationwide, Multicenter Study in Japan, 2004-2013. | 2016 Jul |
2 |
| 28 |
26991414 | Impact of ribavirin dosage in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin combination therapy. | 2016 Oct |
1 |
| 29 |
27110259 | The Role of Polymorphisms Near the IL28B Gene on Response to Peg-Interferon and Ribavirin in Thalassemic Patients With Hepatitis C. | 2016 Jan |
2 |
| 30 |
27140229 | Short article: Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study. | 2016 Aug |
2 |
| 31 |
27156332 | Correlation Study Between IL-28B Gene Polymorphism (rs8099917SNP) and Sustained Virological Response in Iranian Patients with Chronic Hepatitis C. | 2016 |
2 |
| 32 |
27167219 | Randomized Trial Evaluating the Impact of Ribavirin Mono-Therapy and Double Dosing on Viral Kinetics, Ribavirin Pharmacokinetics and Anemia in Hepatitis C Virus Genotype 1 Infection. | 2016 |
1 |
| 33 |
27313635 | The Association of Substitutions in the Hepatitis C Virus Subtype 1b Core Gene and IL28B Polymorphisms With the Response to Peg-IFNα-2a/RBV Combination Therapy in Azerbaijani Patients. | 2016 May |
3 |
| 34 |
27388623 | Influence of Ribavirin Serum Levels on Outcome of Antiviral Treatment and Anemia in Hepatitis C Virus Infection. | 2016 |
1 |
| 35 |
27498543 | Can IFNL3 polymorphisms predict response to interferon/ribavirin treatment in hepatitis C patients with genotype 3? | 2016 Oct |
2 |
| 36 |
27525598 | Genome-wide association of IL-28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C in a Tunisian population. | 2016 Jan |
3 |
| 37 |
27541605 | Pretreatment serum levels of interferon-gamma-inducible protein-10 are associated with virologic response to telaprevir-based therapy. | 2016 Dec |
2 |
| 38 |
27660680 | Predictive potential of IL-28B genetic testing for interferon based hepatitis C virus therapy in Pakistan: Current scenario and future perspective. | 2016 Sep 18 |
1 |
| 39 |
27799970 | Polymorphism of IL-28B Gene (rs12979860) in HCV Genotype 1Patients Treated by Pegylated Interferon and Ribavirin. | 2016 Summer |
3 |
| 40 |
28144454 | Role of IL28-B Polymorphism (rs12979860) on Sustained Virological Response to Pegylated Interferon/Ribavirin in Iranian Patients With Chronic Hepatitis C. | 2016 Sep |
2 |
| 41 |
24849518 | Factors associated with sustained virological response in 24-week telaprevir-based triple therapy for chronic hepatitis C genotype 1b patients with the IL28B minor genotype. | 2015 Apr |
1 |
| 42 |
24995561 | Association of interleukin 28B polymorphism and mutations in the NS5A region of hepatitis C virus genotype 2 with interferon responsiveness. | 2015 Jan |
1 |
| 43 |
25382001 | Baseline sensitivity of T cells to alpha-IFN correlates with sustained virological response to IFN-based triple therapy in HCV infection. | 2015 Jun |
1 |
| 44 |
25391769 | Frequency of interleukin 28B rs12979860 C>T variants in Filipino patients chronically infected with hepatitis B virus. | 2015 Mar |
1 |
| 45 |
25462177 | Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy. | 2015 Jan |
1 |
| 46 |
25470790 | Impact of IL28B genotype on first-week response to telaprevir-based therapy in HIV-HCV coinfection. | 2015 |
1 |
| 47 |
25501286 | Association of serum IFN-λ3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection. | 2015 Aug |
2 |
| 48 |
25580859 | Multicenter prospective study to optimize the efficacy of triple therapy with telaprevir in patients with genotype 1b hepatitis C virus infection according to an algorithm based on the drug Adherence, IL-28B Gene Allele and Viral Response Trial (AG & RGT). | 2015 Nov |
1 |
| 49 |
25652367 | IL28B rs12980275 polymorphism shows association with response to treatment in Pakistani patients with chronic hepatitis C. | 2015 May |
1 |
| 50 |
25687192 | Baseline factors associated with treatment response in patients infected with hepatitis C virus 1b by stratification of IL28B polymorphisms. | 2015 Apr |
1 |